Eureka projects

Medicines with strongly enhanced in vivo stability, optimal receptor interaction, and early indication of clinical success.

Development of a large-scale production process for dendritic cell vaccines for the treatment of cancer

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.